Page 41 - Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

State health department to host Feb. 18 webinar on COVID-19 vaccine phases Posted: February 17, 2021 322 The Washington State Department of Health will host a live webinar Thursday, Feb. 18 to discuss the phasing and rollout of COVID-19 vaccines in state. The webinar, “Understanding WA’s COVID-19 Vaccine Phases,” will feature Umair A. Shah, MD, MPH, Secretary of Health; SheAnne Allen, COVID-19 vaccine director and Dr. Christopher Chen, medical director – Medicaid, Washington Health Care Authority. The conversation will be moderated by Louis Shackelford, HIV Vaccine Trials Netw...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

University System of Maryland (USM) effort includes video message, joint statement, and stepped-up campus advocacy activities. University of Maryland, Baltimore (UMB) President Bruce E. Jarrell, MD, FACS, has joined University System of Maryland (USM) Chancellor Jay A. Perman, MD, and presidents of the system’s other 11 universities in a special promotional effort to encourage COVID-19 vaccinations across Maryland. This multimedia campaign — designed to dovetail with state activities to promote the safety and efficacy of vaccines, especially in communities with vaccine hesitancy — also ...

Building trust in safe and effective COVID-19 vaccines Convincing millions to get vaccinated will take more than data, facts and figures January 21, 2021 • By Sabin Russell / Fred Hutch News Service Anthony Jackson, security coordinator for Fred Hutchinson Cancer Research Center, receives a dose of the new Pfizer-BioNTech COVID-19 vaccine on Jan. 19, 2021, at a new vaccine clinic set up on the Fred Hutch campus. Photo by Robert Hood / Fred Hutch News Service On the morning of Dec. 29, as a historic and harrowing year was drawing to ...

Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released An investigational COVID-19 vaccine developed by Janssen Pharmaceuticals appears to be safe and effective at preventing moderate and severe COVID-19 in adults, according to an interim analysis of Phase 3 clinical data conducted Jan. 21. The vaccine, called Ad.26.COV2.S or JNJ-78436725, requires only a single injection and can be stored in a refrigerator for months. The interim analysis assessed 468 cases of symptomatic COVID-19 among 44,325 adult volunteers in Argentina, Brazil, Chile, Colombia, Mexic...